About AVT
Browse Articles
Authors
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 20 Issue 1 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 1888 results:

Original article

Recent trends in early stage response to combination antiretroviral therapy in Australia

Hamish McManus, Jennifer F Hoy, Ian Woolley, Mark A Boyd, Mark D Kelly, Brian Mulhall, Norman J Roth, Kathy Petoumenos, Matthew G Law, the Australian HIV Observational Database

10.3851/IMP2774


Original article

On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy

Yi-Wen Huang, Shoichi Takahashi, Masataka Tsuge, Chi-Ling Chen, Ting-Chuan Wang, Hiromi Abe, Jui-Ting Hu, Ding-Shinn Chen, Sien-Sing Yang, Kazuaki Chayama, Jia-Horng Kao

10.3851/IMP2777


Original article

A randomized study of standard versus double dose oseltamivir for treating influenza in the community

Rashmi Dixit, Gulam Khandaker, Peter Hay, Kenneth McPhie, Janette Taylor, Harunor Rashid, Leon Heron, Dominic Dwyer, Robert Booy

10.3851/IMP2807


Original article

Impact of prior virologic failure and nucleos(t)ide genotypic resistance mutations on the efficacy of switching from ritonavir-boosted protease inhibitors to raltegravir

José L Blanco, Ana Gonzalez-Cordón, Josep M Llibre, Marta Calvo, Felix Gutierrez, Daniel Podzamczer, Montserrat Laguno, Emilio Fumero, Javier Murillas, Josep Mallolas, Maria Martinez-Rebollar, Montserrat Lonca, Iñaki Perez, Josep M Gatell, Esteban Martinez

10.3851/IMP2812


Original article

Switching safely: pharmacokinetics, efficacy and safety of switching efavirenz to maraviroc twice-daily in patients on suppressive antiretroviral therapy

Laura Waters, Akil Jackson, Laura Else, Neesha Rockwood, Sally Newell, David Back, Mark Nelson, Brian Gazzard, Marta Boffito

10.3851/IMP2817


Free
Correction

Recent trends in early stage response to combination antiretroviral therapy in Australia

Hamish McManus, Jennifer F Hoy, Ian Woolley, Mark A Boyd, Mark D Kelly, Brian Mulhall, Norman J Roth, Kathy Petoumenos, Matthew G Law, the Australian HIV Observational Database

10.3851/IMP2822


Original article

Safety, pharmacokinetics and pharmacodynamics of the oral Toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis C

Eric Lawitz, Daniel Gruener, Thomas Marbury, John Hill, Lynn Webster, David Hassman, Anh-Hoa Nguyen, Stefan Pflanz, Erik Mogalian, Anuj Gaggar, Benedetta Massetto, G Mani Subramanian, John G McHutchison, Ira M Jacobson, Bradley Freilich, Maribel Rodriguez-Torres

10.3851/IMP2845


Original article

Generation of a chimeric hepatitis C replicon encoding a genotype-6a NS3 protease and assessment of boceprevir (SCH503034) sensitivity and drug-associated mutations

Amanda L Aloia, Nicholas S Eyre, Stuart Black, Stephen J Bent, Adriana Gaeguta, Zhuyan Guo, Sumudu K Narayana, Robert Chase, Stephen Locarnini, Jill M Carr, John A Howe, Michael R Beard

10.3851/IMP2850


Original article

Effect of drug-resistance mutations on antiviral agents in HCV patients

Grey Liu, Qingxian Cai, Zhanyi Li, Xiaoqiong Shao, Qiumin Luo, Xiaohong Zhang, Zhixin Zhao

10.3851/IMP2852


Short communication

Vitamin D pathway gene variants and HCV-2/3 therapy outcomes

Jessica Cusato, Sarah Allegra, Lucio Boglione, Amedeo De Nicolò, Lorena Baietto, Giuseppe Cariti, Giovanni Di Perri, Antonio D’Avolio

10.3851/IMP2853


Page:
Copyright © Nucleus Global 2015. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.